Linda M Arterburn

Summary

Affiliation: Martek Biosciences
Country: USA

Publications

  1. ncbi request reprint Distribution, interconversion, and dose response of n-3 fatty acids in humans
    Linda M Arterburn
    Martek Biosciences Corporation, Columbia, MD, USA
    Am J Clin Nutr 83:1467S-1476S. 2006
  2. doi request reprint Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid
    Linda M Arterburn
    Pharmacology and Toxicology, Alba Therapeutics, Baltimore, MD, USA
    J Am Diet Assoc 108:1204-9. 2008
  3. doi request reprint Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6)
    Bindi Dangi
    Martek Biosciences Corp, 6480 Dobbin Road, Columbia, MD 21045, USA
    Biochem Pharmacol 79:251-60. 2010
  4. doi request reprint Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo
    Julie M Nauroth
    Martek Biosciences Corporation, 6480 Dobbin Road, Columbia, MD 21045, USA
    Lipids 45:375-84. 2010
  5. ncbi request reprint Bioequivalence of Docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food
    Linda M Arterburn
    Martek Biosciences Corporation, 6480 Dobbin Road, Columbia, MD 21045, USA
    Lipids 42:1011-24. 2007
  6. pmc Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6)
    Bindi Dangi
    Martek Biosciences Corporation, Columbia, Maryland 21045, USA
    J Biol Chem 284:14744-59. 2009
  7. ncbi request reprint Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study
    John D Lloyd-Still
    Rush University Medical Center, Chicago, Illinois, USA
    Nutrition 22:36-46. 2006
  8. ncbi request reprint Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide
    J Thomas Brenna
    Division of Nutritional Sciences, Cornell University, Ithaca, NY 14850, USA
    Am J Clin Nutr 85:1457-64. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Distribution, interconversion, and dose response of n-3 fatty acids in humans
    Linda M Arterburn
    Martek Biosciences Corporation, Columbia, MD, USA
    Am J Clin Nutr 83:1467S-1476S. 2006
    ..We conclude that the most predictable way to increase a specific long-chain n-3 fatty acid in plasma, tissues, or human milk is to supplement with the fatty acid of interest...
  2. doi request reprint Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid
    Linda M Arterburn
    Pharmacology and Toxicology, Alba Therapeutics, Baltimore, MD, USA
    J Am Diet Assoc 108:1204-9. 2008
    ....
  3. doi request reprint Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6)
    Bindi Dangi
    Martek Biosciences Corp, 6480 Dobbin Road, Columbia, MD 21045, USA
    Biochem Pharmacol 79:251-60. 2010
    ..Analysis of the metabolic stability and identification of metabolites of these compounds could play an important role in the design of better analogs with longer durations of action and hence better efficacy...
  4. doi request reprint Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo
    Julie M Nauroth
    Martek Biosciences Corporation, 6480 Dobbin Road, Columbia, MD 21045, USA
    Lipids 45:375-84. 2010
    ..Together, these results demonstrate that DPAn-6 has anti-inflammatory activity and enhances the effect of DHA in vitro and in vivo. Thus, DHA-S algal oil may have potential for use in anti-inflammatory applications...
  5. ncbi request reprint Bioequivalence of Docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food
    Linda M Arterburn
    Martek Biosciences Corporation, 6480 Dobbin Road, Columbia, MD 21045, USA
    Lipids 42:1011-24. 2007
    ..Adverse event monitoring revealed an excellent safety and tolerability profile. Two different algal oil capsule supplements and an algal oil-fortified food represent bioequivalent and safe sources of DHA...
  6. pmc Biogenic synthesis, purification, and chemical characterization of anti-inflammatory resolvins derived from docosapentaenoic acid (DPAn-6)
    Bindi Dangi
    Martek Biosciences Corporation, Columbia, Maryland 21045, USA
    J Biol Chem 284:14744-59. 2009
    ..These oxygenated DPAn-6 compounds can thus be categorized as a new class of DPAn-6-derived resolvins...
  7. ncbi request reprint Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study
    John D Lloyd-Still
    Rush University Medical Center, Chicago, Illinois, USA
    Nutrition 22:36-46. 2006
    ..The study objective was to determine bioavailability, tissue accretion, and safety of a large dose of an algal source of docosahexaenoic acid (DHA) triacylglycerol and to observe effects on lung function in patients with CF...
  8. ncbi request reprint Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide
    J Thomas Brenna
    Division of Nutritional Sciences, Cornell University, Ithaca, NY 14850, USA
    Am J Clin Nutr 85:1457-64. 2007
    ..This comprehensive analysis of breast-milk DHA and AA indicates a broad range of these nutrients worldwide and serves as a guide for infant feeding...